About US
Contact us
-
Second Genome Enters Into Agreement with Pfizer Inc. on Microbiome Research Initiative in ObesitySecond Genome announced has entered into an agreement with Pfizer Inc. to conduct extensive microbiome research in a large observational study aimed at gaining new insights into obesity and metabolic2014/5/6
-
Otsuka's tuberculosis drug Deltyba secures marketing approval in EUJapan-based Otsuka Pharmaceutical has received marketing authorisation from the European Commission for Deltyba (delamanid) to use as part of an appropriate combination regimen for pulmonary multidrug2014/5/5
-
Allergan's Botox gets positive opinion from Irish Medicines BoardAllergan has received a positive opinion for Botox (Botulinum Toxin Type A) from the Irish Medicines Board serving as reference member state in the mutual recognition procedure (MRP) for treatment of2014/5/5
-
GSK's Incruse Ellipta gets FDA approval to treat airflow obstruction in COPD patientsGlaxoSmithKline (GSK) has received US Food and Drug Administration (FDA) approval for Incruse Ellipta (umeclidinium) as an anticholinergic indicated for the once-daily, maintenance treatment of airflo2014/5/4
-
US FDA grants priority review for AstraZeneca's ovarian cancer drug olaparibThe US Food and Drug Administration (FDA) has granted priority review for AstraZeneca's new drug application (NDA) of olaparib for treatment of ovarian cancer. Olaparib is an oral poly ADP-ribose pol2014/5/4
-
Novozymes' Half-Life Extension Technology Reaches Landmark Milestone as GSK's Albiglutide is Granted FDA Marketing ApprovalFDA has granted marketing approval to GlaxoSmithKline's new Type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-l2014/4/30
-
Janssen's type 2 diabetes drug Vokanamet gets European Commission approval in EUJanssen-Cilag International (Janssen) has received approval from the European Commission (EC) for use of Vokanamet in the European Union (EU) as a treatment for adults with type 2 diabetes mellitus to2014/4/30
-
Boehringer gets EMA positive opinion for Pradaxa to treat DVT and PEBoehringer Ingelheim has received positive opinion from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP) recommending approval of Pradaxa (dabigatran etexilate) for2014/4/29
-
NICE recommends afatinib for treatment of lung cancerThe National Institute for Health and Care Excellence (NICE) in the UK has issued its final health technology appraisal recommending afatinib as a first-line treatment option for patients with advance2014/4/29
-
Apricus's erectile dysfunction drug Vitaros gets national phase approval in SpainUS-based pharmaceutical firm Apricus Biosciences has received national phase approval from the Spanish Agency for Medicines and Health Products (AEMPS) for Vitaros, a topical on-demand treatment for e2014/4/28